UNSPSC 85541254: Extirpation of matter from mesenteric lymphatic, percutaneous approach

This classification denotes the group of activities that yields a surgical intervention or procedure to extirpation of matter from mesenteric lymphatic, percutaneous approach. This surgical intervention or procedure is listed in the World Health Organization's International Statistical Classification of Diseases and Related Health Problems or ICD-10 as code 07CB3ZZ

UNSPSC 85541254 Extirpation of matter from mesenteric lymphatic, percutaneous approach is a Commodity code that shows little relevant recent activity aligned with its clinical procedural scope. The recent opportunities tagged under this code span disability medical evaluation coordination, surgical benefit carve-out program management, occupational medical surveillance, emergency medical services for detained youth, pharmacy benefit management, and temporary health professional staffing — none of which constitute percutaneous extirpation procedures. The mismatch suggests either classification drift or miscoding in the source material rather than active state and local procurement for the procedure itself.

The issuing bodies in the recent opportunities include city retirement offices (City of Phoenix), municipal health systems (City of Long Beach), state transportation departments (Washington State Department of Transportation), county juvenile probation and health systems (Harris County, Santa Clara County), and county boards of commissioners (Collier County). The geographic spread spans Arizona, California, Florida, and Washington. Representative recent opportunities include the City of Phoenix Retirement Office's RFP for independent medical evaluation services (RTMRFP26001, due October 16, 2026) supporting disability determinations for approximately 75 annual public safety pension applications at a five-year contract value of $750,000, and the Washington State Department of Transportation's RFP for occupational medical surveillance services across 14 ferry system locations (RFP20260825, due October 9, 2026) with evaluation weighted 40 percent on cost and 60 percent on capability factors. Given the code's nominal definition and the absence of solicitations actually seeking percutaneous lymphatic procedures, the code does not represent a meaningful procurement target under its stated scope.